
OKYO Pharma Limited - Ordinary Shares
Share · US6793451088 · OKYO (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of OKYO Pharma Limited - Ordinary Shares
No Price
28.04.2026 20:00
Current Prices from OKYO Pharma Limited - Ordinary Shares
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
NASDAQ |
OKYO
|
USD
|
28.04.2026 20:00
|
1,58 USD
| 0,00 USD |
IEX |
OKYO
|
USD
|
28.04.2026 19:59
|
1,59 USD
| 0,005 USD
+0,32 %
|
Company Profile for OKYO Pharma Limited - Ordinary Shares Share
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Company Data
Name OKYO Pharma Limited - Ordinary Shares
Company OKYO Pharma Limited
Symbol OKYO
Website
https://www.okyopharma.com
Primary Exchange
NASDAQ
NASDAQ
ISIN US6793451088
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Gary S. Jacob
Market Capitalization 74 Mio
Country United Kingdom
Currency USD
Employees 0,0 T
Address 55 Park Lane, W1K 1NA London
IPO Date 2022-05-17
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | OKYO |
More Shares
Investors who hold OKYO Pharma Limited - Ordinary Shares also have the following shares in their portfolio:
